EUVIMEDEUVIMED entdecken
ValidierungsstudieVergleichsstudieOpen Access · CC BY 4.0

AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation

Beibei Jiang, Harriet L Lancaster, Michael P A Davies, Jan-Willem C Gratama, Mario Silva, Daiwei Han, Jaeyoun Yi, Carlijn M van der Aalst, Anand Devaraj, Marjolein A Heuvelmans, John K Field, Matthijs Oudkerk

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2025.116137 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Beibei Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; Institute for Diagnostic Accuracy, Groningen, the Netherla…. Hauptthemen laut MEDLINE: Artificial Intelligence, Early Detection of Cancer, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Roy Castle Lung Cancer Foundation, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceEarly Detection of CancerLung NeoplasmsAgedFemaleHumansMaleMiddle AgedConsensusFollow-Up StudiesTime FactorsTomography, X-Ray ComputedTumor BurdenUnited KingdomConsensus Statements as Topic

Stichwörter der Autor:innen

Artificial IntelligenceComparative studyComputed tomographyGrowth-rateLow-Dose CTLung cancer screeningPulmonary noduleScreening follow-upVDT

Autor:innen und Institutionen

  • Department of Public Health, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; Institute for Diagnostic Accuracy, Groningen, the Netherlands.
  • Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Department of Radiology and Nuclear Medicine, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.
  • Department of Medicine and Surgery (DiMeC), Scienze Radiologiche, University of Parma, Parma, Italy.
  • Institute for Diagnostic Accuracy, Groningen, the Netherlands.

Förderung

  • China Scholarship Council
  • Roy Castle Lung Cancer Foundation
  • National Institute for Health and Care Research
  • Rijksuniversiteit Groningen
  • Horizon 2020
  • Horizon 2020 Societal Challenges

Zitieren

APA

Jiang, B., Lancaster, H. L., Davies, M. P. A., Gratama, J. C., Silva, M., Han, D., Yi, J., van der Aalst, C. M., Devaraj, A., Heuvelmans, M. A., Field, J. K., & Oudkerk, M. (2026). AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116137

Vancouver

Jiang B, Lancaster HL, Davies MPA, Gratama JC, Silva M, Han D, et al. AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2025.116137

BibTeX
@article{Jiang2026,
  author = {Jiang, Beibei and Lancaster, Harriet L and Davies, Michael P A and Gratama, Jan-Willem C and Silva, Mario and Han, Daiwei and Yi, Jaeyoun and van der Aalst, Carlijn M and Devaraj, Anand and Heuvelmans, Marjolein A and Field, John K and Oudkerk, Matthijs},
  title = {AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2025.116137}
}
Kostenlos starten →